EP 2203432 A4 20110427 - METHOD OF TREATMENT
Title (en)
METHOD OF TREATMENT
Title (de)
BEHANDLUNGSVERFAHREN
Title (fr)
PROCÉDÉ DE TRAITEMENT
Publication
Application
Priority
- US 2008076519 W 20080916
- US 97417507 P 20070921
Abstract (en)
[origin: WO2009039091A1] This invention relates to the use of a sulfonamide substituted diphenyl urea compound to treat cystic fibrosis, or the symptoms associated with cystic fibrosis.
IPC 8 full level
A61K 31/17 (2006.01); A61K 31/18 (2006.01); C07D 241/04 (2006.01)
CPC (source: EP)
A61K 31/17 (2013.01); A61K 31/18 (2013.01)
Citation (search report)
- [Y] WO 2004039775 A2 20040513 - SMITHKLINE BEECHAM CORP [US], et al
- [Y] DE 102005023834 A1 20060524 - BAYER HEALTHCARE AG [DE]
- [Y] EIDELMAN O ET AL: "Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery", AMERICAN JOURNAL OF PHARMACOGENOMICS, WOLTERS KLUWER HEALTH, XX, vol. 1, no. 3, 1 January 2001 (2001-01-01), pages 223 - 240, XP009146190, ISSN: 1175-2203
- See references of WO 2009039091A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2009039091 A1 20090326; EP 2203432 A1 20100707; EP 2203432 A4 20110427
DOCDB simple family (application)
US 2008076519 W 20080916; EP 08831660 A 20080916